Global Investor Forum Contact

Hanneke Schuitemaker

Global Head of Viral Vaccine Discovery and Translational Medicine, Janssen Vaccines

Session

14:15 - 15:25
From treatment to prevention

Hanneke Schuitemaker is the Global Head of Viral Vaccine Discovery and Translational Medicine in the Infectious Disease and Vaccines Therapeutic Area of Janssen Vaccines and a professor in virology at the Academic Medical Center of the University of Amsterdam.
She is a medical biologist by training, received her PhD in Medicine in 1992 at the University of Amsterdam and worked for more than 20 years on HIV-1 pathogenesis.
In her current position, she is responsible for the port-folio of viral vaccine programs that are in the phase of discovery or early development. Most advanced programs in that port-folio are vaccine candidates for HIV, Ebola, Zika, RSV.

Abstract

Challenges of future pandemics and infectious diseases
In our hyper-connected world, we are facing the escalating threat of epidemics from infectious diseases. Each year, infectious diseases account for 16% of deaths worldwide, and it is widely understood that infectious diseases will spread more and more easily in the future due to globalization, population growth and aging, antimicrobial resistance, increasing travel, the development of megacities and climate change.
Janssen is dedicated to advancing human health by developing potentially transformational vaccines to prevent and intercept some of these life-threatening diseases, such as HIV, Influenza and Ebola, which offer pandemic threat.
End of 2017, the company initiated a Phase 2b proof-of-concept study (HPX2008/HVTN 705 – also known as “Imbokodo”) with partners to evaluate a mosaic-based preventive HIV-1 vaccine. The study will assess whether the vaccine regimen is effective in reducing the incidence of HIV infection among 2,600 women in sub-Saharan Africa.
Janssen is also committed to develop a vaccine to help prevent the spread of Ebola. Ongoing outbreaks demonstrate the importance of disease surveillance and management, the value of strong health systems, and the need to finish the job of developing safe and effective vaccines to help protect communities and prevent a resurgence of the virus.
During “Challenges of future pandemics and infectious diseases” Hanneke Schuitemaker, Vice President, Global Head of Viral Vaccine Discovery and Translational Medicine will discuss the challenges of future infectious diseases pandemics and the potential vaccines could provide to avoid future outbreaks.

Kees Been
Lysosomal Therapeutics Inc.

Erik van de Berg
AM-Pharma

René Bernards
Qameleon Therapeutics & NKI

Annelien Bredenoord
UMC Utrecht

Carine van den Brink
AXON Lawyers

Danielle Curfs
Chemelot InSciTe
Jenny Dankelman
TU Delft
Diederik Dippel
Erasmus MC

Cornelia van Duijn
Erasmus MC

Lude Franke
UMCG
Thibault Helleputte
DNAlytics
Mark van Houdenhoven
St. Maartenskliniek
Henk Joos
Flanders Bio
Peter de Keizer
Erasmus MC
Tim Knotnerus
AM-Pharma, PRIMER Professionals
Angus Livingstone
Oncode Institute
Travis McCready
Massachusetts Life Sciences Center

Mirjam Mol
Pivot Park

Barend Mons
DTL & LUMC
Timothy Noël
Eindhoven University of Technology
Jacquelien Noordhoek
Dutch CF Foundation
Violet Petit-Steeghs
Athena Institute
Thomas Plochg
NPHF
Dirk Jan van der Pol
Ordina
Anne Portwich
LSP
Elisabeth van Rossum
Erasmus MC
André van de Sande
Xendo
Marlies Schijven
AMC
Hans Schikan
Topsector LSH
Hanneke Schuitemaker
Janssen Vaccines
Frits Schut
V.O. Patents & Trademarks
Marieke Schuurmans
UMC Utrecht
Jacob Seidell
VU
Agaath Sluijter
Medical Delta
Thijs Spigt
Erasmus MC
Marianne van der Steen
Maastricht University
Maarten Steinbuch
Eindhoven University of Technology
Onno van de Stolpe
Galapagos
Werner Verbiest
Janssen Diagnostics
Martine de Vries
LUMC

Edward van Wezel
BioGeneration Ventures

Jan van de Winkel
Genmab

Loek Winter
DC Klinieken

Hanneke Heeres
Health~Holland
Caroline Duterloo
Medical Delta
Paul Korte
Janssen
Aart Jan van der Lelij
Erasmus MC
Werner Brouwer
Erasmus University
Arnout van Diermen
Novo Nordisk

Ton van der Steen
Erasmus MC & Medical Delta

Sponsors & Partners
Main partner
Host sponsor
Host sponsor
Host sponsor
Platinum sponsor
Platinum sponsor
Platinum sponsor
Platinum sponsor
Gold sponsor
Silver sponsor
Award sponsor
Award sponsor
© 2018 Innovation for Health